Lyell Immunopharma EPS Diluted (Quarterly) Trends

Lyell Immunopharma Inc (LYEL)

0.9478 +0.03 (+3.40%) USD | NASDAQ | Nov 22, 16:00

0.9478 0.00 (0.00%) After-Hours: 20:00

EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2020. Upgrade now.

Date	Value
September 30, 2024	-0.17
June 30, 2024	-0.18
March 31, 2024	-0.24
December 31, 2023	-0.20
September 30, 2023	-0.20
June 30, 2023	-0.26
March 31, 2023	-0.27
December 31, 2022	-0.03
September 30, 2022	-0.28
June 30, 2022	-0.15

Date	Value
March 31, 2022	-0.28
December 31, 2021	-0.3448
September 30, 2021	-0.20
June 30, 2021	-1.47
March 31, 2021	-0.2267
December 31, 2020	-0.1835
September 30, 2020	-0.1687
June 30, 2020	-0.4754
March 31, 2020	-0.155

Earnings per Share Definition

Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.

Read full definition.

EPS Diluted (Quarterly) Range, Past 5 Years

-1.47

Minimum

Jun 2021

-0.03

Maximum

Dec 2022

-0.2886

Average

-0.20

Median

Sep 2021

EPS Diluted (Quarterly) Benchmarks

Chimerix Inc	-0.26
NovaBay Pharmaceuticals Inc	-0.60
Palatin Technologies Inc	-0.39
iBio Inc	-0.46
Theriva Biologics Inc	-6.81

EPS Diluted (Quarterly) Related Metrics

Net Income (Quarterly)	-44.58M
Revenue (Quarterly)	0.034M
Total Expenses (Quarterly)	50.54M
Enterprise Value	-184.61M
Profit Margin (Quarterly)	-131.1K%
Earnings Yield	-83.35%
Normalized Earnings Yield	-77.96